ArticleAnnals of the rheumatic diseases2020

Lessons from tofacitinib in patients with cardiovascular risk factors: increased pulmonary embolism or isolated (thrombotic) pulmonary occlusion rates?

Thomas DörnerPubMed ↗Publisher ↗

No numbers read from the abstract.